Arterra Bioscience SpaMIL: ARBS

ARBS: Revenue up 43% in 1H 2024, led by strong cosmetic raw material sales growth

· Issued by Arterra Bioscience Spa

Revenue rose 43.18% year-over-year to €2.3 million in 1H 2024, driven by a 49.03% surge in cosmetic raw material sales. Management is confident in meeting 2024 targets, supported by continued growth trends.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Company analysis